9MW2821 Clinical Trials
10 recruitingDrug
Phase 25Phase 13Phase 33
Showing 1–10 of 10 trials
Recruiting
Phase 2
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
Metastatic Breast CancerAdvanced Breast Cancer
Fudan University160 enrolled1 locationNCT06649331
Recruiting
Phase 2
9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer
Urothelial Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.90 enrolled1 locationNCT07314723
Recruiting
Phase 3
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
Advanced Urothelial Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.432 enrolled1 locationNCT06196736
Recruiting
Phase 2
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial CarcinomaUrothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Mabwell (Shanghai) Bioscience Co., Ltd.60 enrolled2 locationsNCT06823427
Recruiting
Phase 2
A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer
Triple-Negative Breast Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.160 enrolled1 locationNCT06492005
Recruiting
Phase 3
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.420 enrolled2 locationsNCT06692166
Recruiting
Phase 1Phase 2
9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer
Advanced Urothelial Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.100 enrolled1 locationNCT06079112
Recruiting
Phase 3
9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
Urothelial Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.460 enrolled1 locationNCT06592326
Recruiting
Phase 1
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.40 enrolled2 locationsNCT05773937
Recruiting
Phase 1
Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)
Bladder Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School30 enrolled1 locationNCT06551233